Katherine Bach Kalin Sellas Life Sciences Group, Inc. (SLS) insider trading activity

Katherine Bach Kalin is Director of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 21,000 shares of SLS, which is worth approximately $28,140. The most recent transaction as insider was on Jan 10, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K

147.06% 3M change

147.06% 12M change

Total Value Held $28,140

Katherine Bach Kalin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2025	BUY Grant, award, or other acquisition	-	12,500 Added 37.31%	21,000 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	6,000 Added 41.38%	8,500 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	2,500 Added 50.0%	2,500 Common Stock

Also insider at

ATHX

ATHERSYS, INC Healthcare

Director

KBK